about
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Progress and problems in understanding and managing primary Epstein-Barr virus infectionsLatent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathwayEpstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosisBinding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expressionInduction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cellsEpstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BimEpigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.Endoplasmic reticulum calcium pumps and cancer cell differentiation.Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.Viral latency and its regulation: lessons from the gamma-herpesviruses.Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expressionGammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.Gammaherpesvirus lytic gene expression as characterized by DNA array.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceEpstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancersTegument protein control of latent herpesvirus establishment and animation.Viral versus cellular BCL-2 proteins.Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression.Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBVPre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexesMolecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?Epigenetic reprogramming of host genes in viral and microbial pathogenesisEBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infectionIs murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification.Effect of high dose vitamin C on Epstein-Barr viral infection.
P2860
Q24336304-235E6F73-0164-488D-AA3F-1FA1F4BCB2F0Q24597706-4C38F969-87D4-4C23-8BD2-D1B05049C886Q24682515-E5848063-91AD-403E-80A6-F45E509030A6Q28731829-7A1C5ADD-7DCF-42B4-9BAD-BFBCF5323751Q31081505-521211FC-53E4-451D-93A8-05620F8F0931Q31111648-852563AA-4261-4FBA-A36A-CF08A356ED90Q33328501-67B13137-CD76-4757-A4E5-7F6004A46BE6Q33474807-1C3477C5-B8D5-449E-A679-D737AC88F843Q33604848-8B8926B1-56B3-474B-B9A6-537A9A90CAF9Q33649613-831F0CA4-2D14-4082-B571-DC2C67A7FF28Q33657311-8C318F49-9EE1-430B-941E-F20222BD5531Q34039189-7FDFE2A3-19C4-4E8B-9A14-C5206E4A1C4FQ34103135-9B76E860-5842-4952-9A27-D22BE228EB69Q34277058-49A20B0C-F475-4193-B353-B31D5AE2834CQ34334212-36BB5864-7CB9-4F8B-AE18-D2E22386694EQ34339844-ADCBC1C7-6E45-4142-AFF8-9CE46D89756BQ34341875-57E7CDB2-5745-4DF4-981C-A354E9284C24Q34535924-5623FBC0-84C8-4412-BCEC-DF76D45852E9Q34712750-BF3FFBD1-D83A-46CE-91B3-45B1985A0FD7Q35091480-3C3394F8-B624-48AE-BAFB-80EE11820BBCQ35165290-AE27B9FB-127C-47DF-A1A5-21D506A39A18Q35196615-1C653727-D888-4959-8072-5B909A8E5F1DQ35826192-01B04F52-CEA5-4CA1-99D7-D7A293A2E875Q36180229-219A707B-883D-407C-A425-730571417298Q36369278-EA20789F-48DA-44C5-9B4E-F6AF0BAAA70FQ36526103-CB7C81BB-B4C0-4778-97BB-E09E04A2860CQ36535405-11B0A160-CDBC-4C33-BB73-A7C81F3392E2Q36747951-BC2FB661-4C74-4004-AD25-E8B6E149D649Q37092673-B2C8101F-4D79-4CC2-BF0E-19AB6FA5D031Q37093792-0183F53A-0976-4940-89D7-B8C4D87940F6Q37192244-0285F663-2C58-4F13-BD3A-AAD2920FD503Q37461274-082DA4E8-737A-4D48-B497-FD30489401FBQ37468665-53008307-AF6A-4C9B-8533-1EEB2071B328Q37563700-5E0D9299-5340-495F-8A92-AF36A2124919Q37781197-AB4FAFEE-29D9-49C3-BE1B-8BB72C557D79Q38156169-4EDCA032-D23D-4287-928C-DF42C36A13D8Q38186778-0D58E9FF-B043-4434-860A-4B1DD68B7492Q38999750-D5CBF20E-0826-4C2E-87C8-85825CB1C524Q39042093-083A7582-5FDA-470C-9DA8-481C0470EAE0Q39427990-32348BBE-D64A-44D5-AEE1-48763EBE7DCE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular virology of Epstein-Barr virus.
@ast
Molecular virology of Epstein-Barr virus.
@en
Molecular virology of Epstein-Barr virus.
@nl
type
label
Molecular virology of Epstein-Barr virus.
@ast
Molecular virology of Epstein-Barr virus.
@en
Molecular virology of Epstein-Barr virus.
@nl
prefLabel
Molecular virology of Epstein-Barr virus.
@ast
Molecular virology of Epstein-Barr virus.
@en
Molecular virology of Epstein-Barr virus.
@nl
P2860
P356
P1476
Molecular virology of Epstein-Barr virus.
@en
P2093
Bornkamm GW
Hammerschmidt W
P2860
P304
P356
10.1098/RSTB.2000.0781
P407
P577
2001-04-01T00:00:00Z